<DOC>
	<DOCNO>NCT00250952</DOCNO>
	<brief_summary>It think amount fluid use dilute Botox injection effect quality result duration effect treatment upper face rhytides , even though dose remains . The study design test thinking , use crow 's foot wrinkle treatment area .</brief_summary>
	<brief_title>Study Determine If Volume Used Dilute BOTOX Cosmeticâ„¢ Injection Affects Its Overall Effect Duration .</brief_title>
	<detailed_description>It think amount fluid use dilute Botox injection effect quality result duration effect treatment upper face rhytides , even though dose remains . 20 female subject ( 10 per site ) , fit inclusion/exclusion criterion study participation inject 5 unit Botox ( one injection side ) crow 's foot area . The injection prepare one side randomly receive five fold difference volume dilution . Response treatment evaluate 14 day , 30 day , 60 day 90 day injection visit . Standardized photography take visit . Analysis photographs lateral orbital ( crow 's foot rhytides ) maximum attempt contraction ( maximum smile ) do Canfield Scientific , Inc. , use specialized software program create detect measure change .</detailed_description>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<criteria>Female outpatient ; least 18 year age Subjects childbearing potential must negative urine pregnancy test result Baseline/Screening Visit practice reliable method contraception throughout study . Bilaterally symmetric moderate ( score 2 Allergan Photonumeric Guide Crow 's Feet ) Lateral Orbital Rhytides maximum smile Subjects pregnant , plan pregnancy study period , infant breast feeding , childbearing potential practicing reliable method birth control . Subjects history injection lateral orbital area botulinum toxin type A within one year baseline visit . Subjects history adverse reaction botulinum toxin type A . Subjects diagnosis Myasthenia Gravis , EatonLambert syndrome , Amyotrophic Lateral Sclerosis , disease might interfere neuromuscular transmission . Subjects history facial nerve palsy . Subjects profound atrophy excessive weakness muscle target area injection . Subjects systemic infection infection injection site .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2005</verification_date>
	<keyword>Clinical Practice Variations</keyword>
</DOC>